CutisPharma Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- CutisPharma's estimated annual revenue is currently $17.3M per year.
- CutisPharma received $Undisclosed in venture funding in January 2015.
- CutisPharma's estimated revenue per employee is $201,000
- CutisPharma's total funding is $20M.
- CutisPharma has 86 Employees.
- CutisPharma grew their employee count by 30% last year.
- CutisPharma currently has 16 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Vita Data Scien...||$8.4M||42||50%||N/A|
What Is CutisPharma?
CutisPharma, Inc., based in Wilmington, MA, is a privately held, specialty pharmaceutical company focusing on the development and commercialization of value-added proprietary drug products and technologies in the prescription compounding sector of the pharmaceutical industry. Product line and development efforts initially are focused on providing optimized, more efficient alternatives for the preparation of the nearly 10 million currently compounded prescriptions, by offering FIRST® Unit-of-Use Prescription Compounding Kits. Use of these branded compounding kits will be beneficial to all triad participants, namely physicians, pharmacists, and patients. Three U.S. patents have been issued to the Company with several additional patents pending.keywords:N/A
Number of Employees
Employee Growth %
|Indu Muni||President & CEO|
|Neal Muni||President & CEO|
|Les Swartz||Senior Director, Trade & Distribution|
|Francisco Lozano||Vice President Of Quality||Email Available|
|Twinkle Patel||Manager Contracts and Pricing at Azurity Pharmaceutical||Email Available|
|Zeus Pendon||Senior Director, Formulation Development|
|Paul Spanel||Director, Trade Operations||Email Available|
|Anwar Kabir||Director Of Quality Control|
|Stephen Mullen||Director, Quality Assurance|
|Stephen Torra||Director of Information Technology at Azurity Pharmacueticals|
WOBURN, Mass., March 26, 2019 /PRNewswire/ -- CutisPharma, Inc. announced today the opening of its new corporate headquarters in ...
Massachusetts pharmaceutical company CutisPharma Inc. has acquired Silvergate Pharmaceuticals Inc., creating a new, unified company ...
WILMINGTON, Mass., Jan. 15, 2019 /PRNewswire/ -- CutisPharma, Inc. announced today the appointments of Mike Radice as Chief ...
|2015-01-07||$Undisclosed||Undisclosed||Ampersand Capital Partners||Article|
CutisPharma Executive Hires
|2016-08-02||Steven Dinh||EVP/Chief Scientific Officer||Article|
|2019-01-16||Mike Radice||Chief Commercial Officer||Article|